Pharmaceutical Technology
APRIL 4, 2023
Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. US reliance on India for generic drugs could have supply chain security and quality implications for critical medicines. ©GlobalData.
Pharmacy Checkers
NOVEMBER 21, 2019
The FDA’s capacity to evaluate new and generic drug applications and its oversight over drug manufacturing are why we have this degree of assurance. There are 19,000 approved prescription drugs for marketing in the U.S. Of course, the faster a safe and effective medicine can come to market, the better.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 9, 2022
Water-borne illnesses are also likely to become more common, as increased rain and storm surges contribute to flooding and contaminated run off. To meet the growing demand and market opportunity, a pharma company must ensure it has the resources, capacity, and supply chain to grow.”. Vulnerability .
Pharma in Brief
AUGUST 9, 2021
On July 31, 2021, Health Canada published a Notice of Intent outlining its plan to amend the Food and Drug Regulations ( FDR ) and the Medical Devices Regulations in the spring of 2022. Generic drugs and biosimilars are not eligible for this application pathway. Biologic Drugs. Manufacturing Controls.
Pharmacy Checkers
DECEMBER 12, 2019
The GAO’s preliminary analysis on inspections brings back into light what Katherine Eban so passionately – and dramatically – exposed in her book Bottle of Lies: The Inside Story of the Generic Drug Boom.” Is the EU now the gold standard for combatting drug quality problems and fake meds? Why do I write “exact same”?
Pharmacy Checkers
MAY 1, 2020
The FDA has recently suspended its overseas inspections of drug establishments that manufacture products for the U.S. Albeit there are some new hellish supply chain issues due to the coronavirus, drug importation from those plants is still happening. market since we are not doing inspections now. We need to do more of it now.
XTalks
SEPTEMBER 14, 2020
All this cannot begin to explain the weird reality that the stock markets in the US (and elsewhere) are doing just fine. In fact, financial markets have almost regained most of the losses caused by COVID-19. Here again, the stock markets are functioning in a parallel universe. Drugs and Vaccines. billion in June.
Expert insights. Personalized for you.
130 
Let's personalize your content